Resolvin d1

Resolvin d1 is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 305 references associated with Resolvin d1 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Resolvin d1

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Resolvin d1

MeSH term MeSH ID Detail
Atherosclerosis D050197 85 associated lipids
Insulin Resistance D007333 99 associated lipids
Acute Lung Injury D055371 33 associated lipids
Per page 10 20 | Total 13

PubChem Biomolecular Interactions and Pathways

All references with Resolvin d1

Download all related citations
Per page 10 20 50 100 | Total 185
Authors Title Published Journal PubMed Link
Mustafa M et al. Resolvin D1 protects periodontal ligament. 2013 Am. J. Physiol., Cell Physiol. pmid:23864609
Lee HJ et al. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32. 2013 Int. J. Biochem. Cell Biol. pmid:24120851
Mizwicki MT et al. 1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients. 2013 J. Alzheimers Dis. pmid:23186989
Abdelmoaty S et al. Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release. 2013 PLoS ONE pmid:24086560
Tang Y et al. Proresolution therapy for the treatment of delayed healing of diabetic wounds. 2013 Diabetes pmid:23043160
Zhang X et al. Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3β acetylation. 2013 PLoS ONE pmid:23840712
Sun YB et al. Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney. 2013 PLoS ONE pmid:24391884
Zhang X et al. Resolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating IκBα signaling in human vascular endothelial cells. 2013 Oxid Med Cell Longev pmid:24381712
Xie W et al. Resolvin D1 reduces deterioration of tight junction proteins by upregulating HO-1 in LPS-induced mice. 2013 Lab. Invest. pmid:23857007
Eickmeier O et al. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. 2013 Mucosal Immunol pmid:22785226
Wu D et al. Novel biphasic role of resolvin D1 on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts is partly through PI3K/AKT and ERK2 pathways. 2013 Mediators Inflamm. pmid:24174713
Widgerow AD Cellular resolution of inflammation--catabasis. 2012 Jan-Feb Wound Repair Regen pmid:22276585
Clària J et al. Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. 2012 J. Immunol. pmid:22844113
Quan-Xin F et al. Resolvin D1 reverses chronic pancreatitis-induced mechanical allodynia, phosphorylation of NMDA receptors, and cytokines expression in the thoracic spinal dorsal horn. 2012 BMC Gastroenterol pmid:23092159
Mas E et al. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. 2012 Clin. Chem. pmid:22912397
Martin N et al. Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation. 2012 PLoS ONE pmid:22970103
Dalli J and Serhan CN Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. 2012 Blood pmid:22904297
Jones CN et al. Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions. 2012 Proc. Natl. Acad. Sci. U.S.A. pmid:23185003
Liao Z et al. Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. 2012 Respir. Res. pmid:23199346
Settimio R et al. Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis. 2012 Mediators Inflamm. pmid:23304060

Table of Content